Stock Market Today, Oct. 26: Surgery Partners Skyrockets 48% on $5.7 Billion HealthSpan Acquisition
HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50, today, Oct. 26, 2026.
On October 26, Surgery Partners (SGRY) experienced a significant surge in its stock price, rising by 48% to close at $23.25 per share. The uptick in value was sparked by news of a staggering $5.7 billion all-cash acquisition of the company by HealthSpan Partners, an affiliate of Bon Secours Mercy Health. As a result, investors are closely monitoring the deal's progress, particularly the regulatory steps and the finalization timeline, which is expected to occur in the first quarter of 2027.
Trading activity for SGRY was exceptionally high, with a trading volume of 58.3 million shares, a figure that exceeds its three-month average by a remarkable 1,772%. The company initially went public in 2015 and has since shown a 22% growth since its IPO. In comparison, the S&P 500 (^GSPC) closed at 7,677, marking a gain of 0.70%, while the Nasdaq Composite (^IXIC) reached a closing value of 26,169, up by 0.82%.
Within the peer group of outpatient surgical facilities and ancillary healthcare services, Tenet Healthcare (THC) saw a modest increase of 0.18% to close at $268.94, while HCA Healthcare (HCA) experienced a slight decline of 0.91%, closing at $464.74. The 48% surge in SGRY's share price, following the announcement of the acquisition, suggests that the market is optimistic about the deal going through.
The current trading price for SGRY is slightly below the acquisition price, indicating that investors are expecting the transaction to proceed smoothly.
While the acquisition presents an attractive opportunity for shareholders, the take-private offer price aligns closely with the stock's level from the previous year, suggesting that this could be a strategic "buy-low" opportunity for HealthSpan. For those who are SGRY shareholders, acquiring the available cash and moving forward may be the prudent course of action, especially considering that Bain Capital holds approximately 39% of SGRY's shares and has voted in favor of the deal.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
